|
|
Other links at Articles > Business of Medicine |
| 3. |
Medicare Buy-in Plan Runs Into Strong Opposition
|
|
|
The details of the plan are shrouded in secrecy until the CBO report is released later this week, but in the meantime professional organizations and some legislators are making their opposition known. Medscape Medical News
|
| 5. |
U.S. FDA to Take New Look at Anemia Drugs
|
|
|
U.S. regulators plan to ask outside experts to re-evaluate the use of Amgen Inc and Johnson & Johnson anemia drugs when given to patients with chronic kidney disease. Reuters Health Information
|
|
|